Nurofen Express 200mg Tablets
*Company:
Reckitt Benckiser Ireland LimitedStatus:
UpdatedLegal Category:
Supply through pharmacy onlyActive Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 10 April 2024
File name
IE PIL Nurofen Express 200mg Clean CRN00DDJT PRAC 7.pdf
Reasons for updating
- Change to section 2 - pregnancy, breast feeding and fertility
Updated on 10 April 2024
File name
IE SPC Nurofen Express 200mg Tablets Clean CRN00DDJT PRAC 7.pdf
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
Legal category:Supply through pharmacy only
Updated on 23 October 2021
File name
Nurofen Express 200mg Tabs PIL Apr21.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
Updated on 23 October 2021
File name
Nurofen Express 200mg Tablets SmPC Apr21.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category:Supply through pharmacy only
Updated on 02 April 2020
File name
IE SPC Nurofen Express 200mg Tablets Mar 2020.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category:Supply through pharmacy only
Updated on 02 April 2020
File name
Express 200mg Tablets PIL.pdf
Reasons for updating
- Change to section 4 - possible side effects
Updated on 15 January 2020
File name
Nurofen Express 200 mg Tablets.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 02 August 2018
File name
Nurofen Express 200mg Tablets SPC 12.06.18.pdf
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category:Supply through pharmacy only
Updated on 04 December 2017
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only
Updated on 04 December 2017
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 9 - Date of first authorisation/renewal of the authorisation
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Section 6.6 Instructions for use/handling updated to Special Precautions for disposal and other handling
Renewal date updated to date of last renewal May 2016
Renewal date updated to date of last renewal May 2016
Updated on 16 August 2017
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Section 4.2, 4.3, 4.4, 4.5, 4.8, 5.1 updated with Article 31 text.
Section 4.4 and 4.8 updated with chicken pox warnings.
Section 10 date of revision of text updated.
Section 4.4 and 4.8 updated with chicken pox warnings.
Section 10 date of revision of text updated.
Updated on 15 August 2017
File name
PIL_15038_398.pdf
Reasons for updating
- New PIL for new product
Updated on 15 August 2017
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 4 - possible side effects
Updated on 10 October 2014
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Updated in relation to Article 45
Updated on 07 October 2014
Reasons for updating
- Change to warnings or special precautions for use
- Change to dosage and administration
Updated on 10 April 2014
Reasons for updating
- Change to warnings or special precautions for use
- Change of contraindications
Updated on 12 February 2014
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
- Change due to harmonisation of SPC
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Section 2.0 excipients reworded
Section 4.4 cardiovascular & cerebrovascular effects reworded
Section 4.4 cardiovascular & cerebrovascular effects reworded
Updated on 05 July 2011
Reasons for updating
- New PIL for new product
Updated on 22 June 2011
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
None provided